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Summary
Relaxin-3 is a neuropeptide belonging to the relaxin/insulin superfamily. Studies using rodents 
have revealed that relaxin-3 is predominantly expressed in neurons in the nucleus incertus of 
the pons, projecting axons to forebrain regions including the hypothalamus. There is evidence 
that relaxin-3 is involved in several functions, including food intake and stress responses. We 
generated relaxin-3 gene knockout (KO) mice and examined them using a battery of behavio-
ral tests of sensory/motor functions and emotion-related behaviors. Relaxin-3 KO mice exhib-
ited normal growth and appearance. There was no difference in bodyweight among genotypes 
in both normal and high fat diet feeding. In addition, there were no significant differences 
between wild-type and KO mice in social interaction, depression-like behavior, and short mem-
ory test. However, in the elevated plus maze test, KO mice exhibited a robust increase in the 
tendency to enter open arms, although they exhibited normal performance in a light/dark tran-
sition test and showed no difference from wild-type mice in the open field test. Taken together, 
these results indicate that relaxin-3 KO mice exhibit mild anxiolytic characteristics relative to 
wild-type mice, suggesting that this peptide is involved in anxiety-related behavior.
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Relaxin-3/insulin-like peptide7 is a new member of the insulin/relaxin family.
We first reported the detail distribution of relaxin-3 in the rat brain using immuno-
histochemistry and in situ hybridization (Tanaka et al., 2005). Relaxin-3 is mainly 
expressed in neurons of the nucleus incertus (NI) of the pons, but minor population 
of expressing cells are found in other regions of brainstem such as periaqueductal 
gray and dorsal area to the substantia nigra. The fibers of relaxin-3 neurons ascend to 
widely forebrain regions, particularly dense in the areas which belong to the limbic 
system and in electron microscopy, this peptide is localized in the dense-cored ves-
icles and presumably released into the synaptic cleft. Developmentally relaxin-3 is 
detected along the fourth ventricle from embryonic day 18 at mRNA level and from 
postnatal day 0 at peptide level (Miyamoto et al., 2008). Several functions of relax-
in-3 have been suggested by studies using rats and mice, including a role in food 
intake and stress responses, neuroendocrine function (McGowan et al, 2005; Baner-
jee et al, 2010). We reported that relaxin-3 gene expression in the NI was increased 
in response to restraint stress and intracerebroventricular (icv) administration of 
relaxin-3 induced c-Fos expression in the paravenricular nuleus and enhanced CRF 
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mRNA expression. Moreover plasma ACTH was increased after relaxin-3 icv injection 
(Watanabe et al., 2011a).
In the present study, we generated mice carrying a null mutation in the relaxin-3 
gene in order to investigate the function of this peptide in the whole body. We dis-
rupted exon 1 and exon 2 of the relaxin-3 gene by replacing with a PGK-neomycin 
resistance cassette. A targeting vector was transfected into ES cells derived from 129/
SvJ mouse strain by electroporation. After eight generations of backcrossing with 
C57BL/6N, relaxin-3 null mice were generated by mating heterozygous mice and 
confirmed that the mRNA and peptides of relaxin-3 were never exhibited (Watanabe 
et al., 2011b). These mice grow normally, and are fertile. There were no evident 
abnormalities in the physical characteristics of relaxin-3 KO mice, and no significant 
differences in body temperature, grip strength or wire-hanging time between relax-
Figure 1. Body weight gain of relaxin-3 KO mice under a high fat diet. Body weight gain for relaxin-3-/- (KO), relax-
in-3+/- (HE), and wild-type littermates (WT) was measured weekly. Male (upper) or female (lower) mice were fed a 
normal diet (ND), a 45% high fat diet (HFD), or a 60% HFD from 3 weeks of age. Data were presented as mean ± 
SEM and analyzed with repeated measures ANOVA. Statistical results were shown in graphs.
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in-3 KO and wild-type littermates. A previous study reported that relaxin-3 KO mice 
of mixed 129S5:B6-background showed leaner and smaller than control animals when 
they were fed with high fat diet. We examined feeding normal (13%) diet, and 45% 
and 60% calorie of high fat diet to wild, heterozygote, and KO mice of both genders. 
Animals with high fat gained body weight faster than mice with normal diet. How-
ever, we did not observe any significant change in body weights between genotypes 
until 12 weeks (Fig. 1). 
Using male wild and KO mice of litter mate at 10 weeks, we performed a battery 
of behavioral tests to examine such as anxiety, pain sensation, social interaction, short 
memory and depression (Table1). Among tests for measuring anxiety-like behaviors, 
KO mice showed a significant change compared with the wild phenotype only in the 
elevated plus maze test. They performed a significantly higher percentage of entries 
into the open arms, and spent a higher percentage of their time in the open arms. 
However, there were no significant differences in distance traveled, or the number of 
entries into the arms. There were also no significant differences in light/dark tran-
sition test and open filed test. In other behavioral tests, we did not detect the sig-
nificant differences between genotypes (Table 1). In conclusion from these behavio-
ral screenings, relaxin-3 deficient mice have mild anxiolytic characteristics relative to 
wild-type mice, suggesting that this peptide is involved in anxiety-related behavior.
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Table 1. Results of comprehensive behavioral test of relaxin-3 KO mice.
Tests Results
1. General health / Neurological Screening n.s.
2. Light / Dark Transition Test n.s.
3. Open Field Test n.s.
4. Elevated Plus Maze decreased anxiety
5. Hot Plate Test n.s.
6. Social Interaction Test n.s.
7. Rotarod Test n.s.
8. Social Interaction Test (Crawley version) n.s.
9. Porsolt Swim Test n.s.
10. Y-Maze Test n.s.
11. Fear Condition Test (Contextual & Cued) n.s.
12. Tail Suspension Test n.s.
13. Body Weight n.s.
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